索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]居正烨,陈圣宝,张长青.骨质疏松性椎体压缩性骨折研究进展[J].国际骨科学杂志,2018,01:33-36.
点击复制

骨质疏松性椎体压缩性骨折研究进展(PDF)

《国际骨科学杂志》[ISSN:1673-7083/CN:31-1952/R]

期数:
2018年01期
页码:
33-36
栏目:
综述
出版日期:
2018-01-30

文章信息/Info

Title:
-
作者:
居正烨; 陈圣宝; 张长青
200233, 上海交通大学附属第六人民医院骨科
Author(s):
-
关键词:
骨质疏松;  椎体压缩性骨折;  流行病学;  经皮穿刺椎体成形;  球囊扩张椎体后凸成形
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-7083.2018.01.009
文献标识码:
A
摘要:
骨质疏松性椎体压缩性骨折(OVCF)是最常见的骨质疏松性骨折,多导致腰背部急慢性疼痛和畸形,使患者生活质量下降及远期死亡风险增加。目前相关流行病学研究揭示了OVCF发病率、发病特点及危险因素,为防治工作提供理论基础。轻度OVCF多采用保守治疗,措施包括卧床休息、疼痛控制、佩戴支具及康复治疗等。近年研究提倡对急性伴严重疼痛OVCF行经皮穿刺椎体成形术(PVP)和球囊扩张椎体后凸成形术(PKP),多项研究证实这2种微创手术能显著改善椎体功能、缓解疼痛及降低死亡风险。OVCF后再发骨折风险极高,对原有骨质疏松(OP)的治疗是预防OVCF的关键。该文就近年关于OVCF的研究进展作一综述。
Abstract:
-

参考文献/References

[1] McCarthy J, Davis A. Diagnosis and management of vertebral compression fractures[J]. Am Fam Physician, 2016, 94(1): 44-50.
[2] Ballane G, Cauley JA, Luckey MM, et al. Worldwide prevalence and incidence of osteoporotic vertebral fractures[J]. Osteoporos Int, 2017, 28(5): 1531-1542.
[3] Ling X, Cummings SR, Mingwei Q, et al. Vertebral fractures in Beijing, China: the Beijing osteoporosis project[J]. J Bone Miner Res, 2000, 15(10): 2019-2025.
[4] Cauley JA, Palermo L, Vogt M, et al. Prevalent vertebral fractures in black women and white women[J]. J Bone Miner Res, 2008, 23(9): 1458-1467.
[5] Huang C, Ross PD, Fujiwara S, et al. Determinants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii[J]. Bone, 1996, 18(5): 437-442.
[6] 李石伦, 鞠林林, 陈伟, 等. 老年脊柱骨折的流行病学特征分析[J]. 中华老年骨科与康复电子杂志, 2015(1): 50-54.
[7] Schousboe JT. Epidemiology of vertebral fractures[J]. J Clin Densitom, 2016, 19(1): 8-22.
[8] Kwok AW, Gong JS, Wang YX, et al. Prevalence and risk factors of radiographic vertebral fractures in elderly Chinese men and women: results of Mr. OS(Hong Kong)and Ms. OS(Hong Kong)studies[J]. Osteoporos Int, 2013, 24(3): 877-885.
[9] Ensrud KE, Schousboe JT. Clinical practice. Vertebral fractures[J]. N Engl J Med, 2011, 364(17): 1634-1642.
[10] Tsoumakidou G, Too CW, Koch G, et al. CIRSE guidelines on percutaneous vertebral augmentation[J]. Cardiovasc Intervent Radiol, 2017, 40(3): 331-342.
[11] Cosman F, de Beur SJ, Leboff MS, et al. Erratum to: clinician’s guide to prevention and treatment of osteoporosis[J]. Osteoporos Int, 2015, 26(7): 2045-2047.
[12] Garg B, Dixit V, Batra S, et al. Non-surgical management of acute osteoporotic vertebral compression fracture: a review[J]. J Clin Orthop Trauma, 2017, 8(2): 131-138.
[13] Lee HM, Park SY, Lee SH, et al. Comparative analysis of clinical outcomes in patients with osteoporotic vertebral compression fractures(OVCFs): conservative treatment versus balloon kyphoplasty[J]. Spine J, 2012, 12(11): 998-1005.
[14] Yang H, Liu H, Wang S, et al. Review of percutaneous kyphoplasty in China[J]. Spine(Phila Pa 1976), 2016, 41(Suppl 19): B52-B58.
[15] Wardlaw D, Cummings SR, Van Meirhaeghe J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture(FREE): a randomised controlled trial[J]. Lancet, 2009, 373(9668): 1016-1024.
[16] Van Meirhaeghe J, Bastian L, Boonen S, et al. A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters[J]. Spine(Phila Pa 1976), 2013, 38(12): 971-983.
[17] Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures[J]. N Engl J Med, 2009, 361(6): 569-579.
[18] Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures[J]. N Engl J Med, 2009, 361(6): 557-568.
[19] Clark W, Bird P, Gonski P, et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures(VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial[J]. Lancet, 2016, 388(152): 1408-1416.
[20] Yang EZ, Xu JG, Huang GZ, et al. Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures: a prospective randomized controlled clinical study[J]. Spine(Phila Pa 1976), 2016, 41(8): 653-660.
[21] Edidin AA, Ong KL, Lau E, et al. Morbidity and mortality after vertebral fractures: comparison of vertebral augmentation and nonoperative management in the Medicare population[J]. Spine(Phila Pa 1976), 2015, 40(15): 1228-1241.
[22] Lin JH, Chien LN, Tsai WL, et al. Early vertebroplasty associated with a lower risk of mortality and respiratory failure in aged patients with painful vertebral compression fractures: a population-based cohort study in Taiwan[J]. Spine J, 2017, 17(9): 1310-1318.
[23] Saracen A, Kotwica Z. Complications of percutaneous vertebroplasty: an analysis of 1100 procedures performed in 616 patients[J]. Medicine(Baltimore), 2016, 95(24): e3850.
[24] Luo J, Annesley-Williams DJ, Adams MA, et al. How are adjacent spinal levels affected by vertebral fracture and by vertebroplasty? A biomechanical study on cadaveric spines[J]. Spine J, 2017, 17(6): 863-874.
[25] Bae JS, Park JH, Kim KJ, et al. Analysis of risk factors for secondary new vertebral compression fracture following percutaneous vertebroplasty in patients with osteoporosis[J]. World Neurosurg, 2017, 99: 387-394.
[26] Bawa HS, Weick J, Dirschl DR. Anti-Osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample[J]. J Bone Joint Surg Am, 2015, 97(19): 1555-1562.
[27] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊治指南(2017年)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-443.
[28] Khan AA, Morrison A, Hanley DA, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus[J]. J Bone Miner Res, 2015, 30(1): 3-23.
[29] Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research[J]. J Bone Miner Res, 2010, 25(11): 2267-2294.
[30] Papapoulos S, Lippuner K, Roux C, et al. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study[J]. Osteoporos Int, 2015, 26(12): 2773-2783.
[31] Fujita T, Fukunaga M, Itabashi A, et al. Once-weekly injection of low-dose teriparatide(28.2 μg)reduced the risk of vertebral fracture in patients with primary osteoporosis[J]. Calcif Tissue Int, 2014, 94(2): 170-175.
[32] Watanabe A, Yoneyama S, Nakajima M, et al. Osteosarcoma in sprague-dawley rats after long-term treatment with teriparatide(human parathyroid hormone(1-34))[J]. J Toxicol Sci, 2012, 37(3): 617-629.
[33] Reginster JY, Brandi ML, Cannata-Andía J, et al. The position of Strontium ranelate in Today’s management of osteoporosis[J]. Osteoporos Int, 2015, 26(6): 1667-1671.
[34] Meunier PJ, Roux C, Seeman E, et al. The effects of Strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis[J]. N Engl J Med, 2004, 350(5): 459-468.

备注/Memo

备注/Memo:
通信作者: 张长青 E-mail: zhangcq@sjtu.edu.cn
更新日期/Last Update: 2018-01-30